A novel acylated insulin analog
US-2024374692-A1 · Nov 14, 2024 · US
US8946148B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-8946148-B2 |
| Application number | US-74061908-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 20, 2008 |
| Priority date | Nov 20, 2007 |
| Publication date | Feb 3, 2015 |
| Grant date | Feb 3, 2015 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Modified insulin polypeptides and their uses thereof are provided.
Opening claim text (preview).
What is claimed is: 1. An insulin polypeptide comprising a para-acetyl-phenylalanine substituted at one of the following positions: in the B chain at L17, F25 (SEQ ID NO: 4); and wherein the para-acetyl-phenylalanine is conjugated to one or more lipid molecule(s). 2. The insulin polypeptide of claim 1 wherein the A chain comprises a glycine at posi…
Related publications grouped by family.
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Answers are generated from the same data shown on this page.